HOXA13 deregulation has been sporadically associated to other cancer phenotypes, such as ovarian cancer associated with poor clinical outcome [55], in glioma associated with tumor progression thought Wnt and TG-Beta pathways modulation [56] and thyroid cancers where HOXA13 nuclear expression is associated with different histotypes [29]. This evidence concerns the gene HOXA13 and glioma.